1
Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations
Condition(s):Covid-19; Subjects Vaccinated Against Covid-19Last Updated:August 29, 2022Recruiting
Antibodies: 25478 Clinical Trials, Page 1 of 2548
Hide Studies Not Open or Pending
2
Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers
Condition(s):SARS-CoV-2Last Updated:September 16, 2021Completed
3
Antibodies and Liver Retransplantation
Condition(s):Liver Transplant Failure; Antibody-mediated RejectionLast Updated:January 28, 2019Active, not recruiting
4
SARS-CoV2 Antibodies in Pediatric Patients (COVID-19)
Condition(s):SARS-Cov2Last Updated:January 27, 2022Recruiting
5
Quantitative COVID-19 SARS-CoV-2 Antibody Pre and Post Cardiopulmonary Bypass
Condition(s):Laboratory Assessment SARS-CoV-2 Antibody Levels Before and After Surgery for Patients Requiring Cardiopulmonary BypassLast Updated:May 3, 2022Completed
6
Profiling Spike Protein Antibody Response Post COVID Booster
Condition(s):SARS-CoV-2 Booster; Spike Protein IgG AntibodyLast Updated:July 27, 2022Not yet recruiting
7
Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study
Condition(s):SARS-CoV2 Infection; SARS-CoV2 AntibodiesLast Updated:November 5, 2021Active, not recruiting
8
Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in Patients After Organ Transplantation
Condition(s):SARS-CoV2 Infection; SARS-CoV2 AntibodiesLast Updated:December 17, 2021Recruiting
9
Phase 0/1 Local Application of the Monoclonal Antibody (Mab) sB24M in Patients With Purulent Pyoderma
Condition(s):Pyoderma; Pyoderma Gangrenosum; Pyoderma Vegetans; Pyoderma Gangrenosum Surrounding Surgical StomaLast Updated:November 25, 2022Active, not recruiting
10
Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL
Condition(s):Lymphoma, Non-Hodgkin; Lymphoma, T-CellLast Updated:September 28, 2022Recruiting